A detailed history of Captrust Financial Advisors transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Captrust Financial Advisors holds 15,786 shares of TEVA stock, worth $353,922. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,786
Previous 10,640 48.36%
Holding current value
$353,922
Previous $172,000 65.12%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $81,358 - $97,568
5,146 Added 48.36%
15,786 $284,000
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $135,979 - $185,135
10,640 New
10,640 $172,000
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $3,142 - $4,113
387 Added 3.03%
13,171 $137,000
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $95,624 - $136,788
12,784 New
12,784 $130,000
Q2 2022

Aug 23, 2022

SELL
$7.38 - $10.4 $15,748 - $22,193
-2,134 Reduced 43.9%
2,727 $21,000
Q2 2022

Aug 16, 2022

SELL
$7.38 - $10.4 $2,413 - $3,400
-327 Reduced 6.3%
4,861 $37,000
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $9,448 - $12,103
-1,289 Reduced 19.9%
5,188 $49,000
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $39,460 - $50,899
4,995 Added 337.04%
6,477 $52,000
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $3,691 - $4,573
-357 Reduced 19.41%
1,482 $17,000
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $6,104 - $7,827
709 Added 62.74%
1,839 $18,000
Q3 2020

Nov 17, 2020

BUY
$8.57 - $12.69 $5,047 - $7,474
589 Added 108.87%
1,130 $10,000
Q2 2020

Aug 14, 2020

BUY
$8.12 - $13.12 $4,392 - $7,097
541 New
541 $6,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.